The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation

Journal of the American College of Cardiology

Volumn 45, Issue 10, 2005, Pages 1700-1706

  Krötz, Florian ^a,b   Engelbrecht, Barbara ^a   Buerkle, Martin A ^a   Bassermann, Florian ^c   Bridell, Hanna ^a   Gloe, Torsten ^a   Duyster, Justus ^c   Pohl, Ulrich ^a   Sohn, Hae Young ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTOCHROME C; OXIDIZING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA; SUPEROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REDUCTION KINETICS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CRICETINAE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NADPH OXIDASE; PROTEIN-TYROSINE-PHOSPHATASE; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 18944384066     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.02.039     Document Type: Article

References (34)

1. H. Cai, K.K. Griendling, D.G. Harrison The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases Trends Pharmacol Sci 24 2003 471 478
2. H. Cai, D.G. Harrison Endothelial dysfunction in cardiovascular diseases the role of oxidant stress Circ Res 87 2000 840 844
3. K.K. Griendling, D. Sorescu, M. Ushio-Fukai NAD(P)H oxidase role in cardiovascular biology and disease Circ Res 86 2000 494 501
4. M.S. Wolin, S.A. Gupte, R.A. Oeckler Superoxide in the vascular system J Vasc Res 39 2002 191 207
5. K.K. Griendling, D. Sorescu, B. Lassegue, M. Ushio-Fukai Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology Arterioscler Thromb Vasc Biol 20 2000 2175 2183
6. T.J. Guzik, N.E. West, E. Black Vascular superoxide production by NAD(P)H oxidase association with endothelial dysfunction and clinical risk factors Circ Res 86 2000 E85 E90
7. D. Sorescu, D. Weiss, B. Lassegue Superoxide production and expression of nox family proteins in human atherosclerosis Circulation 105 2002 1429 1435
8. B. Lassegue, R.E. Clempus Vascular NAD(P)H oxidases specific features, expression, and regulation Am J Physiol Regul Integr Comp Physiol 285 2003 R277 R297
9. B.M. Babior NADPH oxidase an update Blood 93 1999 1464 1476
10. H.Y. Sohn, M. Keller, T. Gloe, H. Morawietz, U. Rueckschloss, U. Pohl The small G-protein Rac mediates depolarization-induced superoxide formation in human endothelial cells J Biol Chem 275 2000 18745 18750
11. R.S. Frey, A. Rahman, J.C. Kefer, R.D. Minshall, A.B. Malik PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells Circ Res 90 2002 1012 1019
12. H.K. Shin, Y.K. Kim, K.Y. Kim, J.H. Lee, K.W. Hong Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation prevention by cilostazol Circulation 109 2004 1022 1028
13. S. Shaw, X. Wang, H. Redd, G.D. Alexander, C.M. Isales, M.B. Marrero High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway J Biol Chem 278 2003 30634 30641
14. P.N. Seshiah, D.S. Weber, P. Rocic, L. Valppu, Y. Taniyama, K.K. Griendling Angiotensin II stimulation of NAD(P)H oxidase activity upstream mediators Circ Res 91 2002 406 413
15. F. Krotz, H.Y. Sohn, T. Gloe NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment Blood 100 2002 917 924
16. H.Y. Sohn, T. Gloe, M. Keller, K. Schoenafinger, U. Pohl Sensitive superoxide detection in vascular cells by the new chemiluminescence dye L-012 J Vasc Res 36 1999 456 464
17. H.Y. Sohn, U. Raff, A. Hoffmann Differential role of angiotensin II receptor subtypes on endothelial superoxide formation Br J Pharmacol 131 2000 667 672
18. D.W. McVicar, D.N. Burshtyn Intracellular signaling by the killer immunoglobulin-like receptors and Ly49 Sci STKE 2001 2001 RE1
19. Q. Dong, K.A. Siminovitch, L. Fialkow, T. Fukushima, G.P. Downey Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1 J Immunol 162 1999 3220 3230
20. J.M. Pasquet, L. Quek, S. Pasquet Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI J Biol Chem 275 2000 28526 28531
21. F. Krotz, H.Y. Sohn, T. Gloe, C. Plank, U. Pohl Magnetofection potentiates gene delivery to cultured endothelial cells J Vasc Res 40 2003 425 434
22. F. Krotz, C. Wit, H.Y. Sohn Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo Mol Ther 7 2003 700 710
23. F. Bassermann, T. Jahn, C. Miething Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway J Biol Chem 277 2002 12437 12445
24. M.K. Pathak, T. Yi Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines J Immunol 167 2001 3391 3397
25. B. Cuevas, Y. Lu, S. Watt SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity J Biol Chem 274 1999 27583 27589
26. B.D. Cuevas, Y. Lu, M. Mao Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase J Biol Chem 276 2001 27455 27461
27. M. Ushio-Fukai, K.K. Griendling, P.L. Becker, L. Hilenski, S. Halleran, R.W. Alexander Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 21 2001 489 495
28. S.A. Jones, V.B. O'Donnell, J.D. Wood, J.P. Broughton, E.J. Hughes, O.T. Jones Expression of phagocyte NADPH oxidase components in human endothelial cells Am J Physiol 271 1996 H1626 H1634
29. M. Ushio-Fukai, Y. Tang, T. Fukai Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis Circ Res 91 2002 1160 1167
30. J. Kruger, J.R. Butler, V. Cherapanov Deficiency of Src homology 2-containing phosphatase 1 results in abnormalities in murine neutrophil function studies in motheaten mice J Immunol 165 2000 5847 5859
31. J. Zhang, A.K. Somani, K.A. Siminovitch Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling Semin Immunol 12 2000 361 378
32. T. Marumo, V.B. Schini-Kerth, B. Fisslthaler, R. Busse Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells Circulation 96 1997 2361 2367
33. J.M. Li, A.M. Shah Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells J Biol Chem 277 2002 19952 19960
34. D.P. Vivekananthan, M.S. Penn, S.K. Sapp, A. Hsu, E.J. Topol Use of antioxidant vitamins for the prevention of cardiovascular disease meta-analysis of randomised trials Lancet 361 2003 2017 2023